India to Sri Lanka: Atorvastatin Export Trade Route

The India to Sri Lanka Atorvastatin corridor is one of India's established pharmaceutical export routes, with 436 shipments documented worth a combined $13.7M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's atorvastatin manufacturing sector.

Across 33 active suppliers, the average shipment value stands at $31.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with atorvastatin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 13.7%, placing it at rank #10 among India's top atorvastatin export destinations globally.

On the import side, key buyers of Indian atorvastatin in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED , BREATHEFREE LANKA PVT LTD and 56 others. SUNSHINE HEALTHCARE LANKA LIMITED is the single largest importer with 112 shipments valued at $6.2M USD.

India's atorvastatin exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 77 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 33 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ZYDUS LIFESCIENCES LIMITED , CIPLA LIMITED — together account for 67% of total trade value on this route. The average shipment value of $31.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as atorva 20 tab 10x10 tablets(atorvastatincalcium)(10x10) and atorva 40 tab. (10x10)(atorvastatin calcium)(10 x 10 t), suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer with 112 shipments worth $6.2M USD — representing 46% of all atorvastatin imports from India on this route. A total of 59 buyers are active on this corridor.